New insights into molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria.
Paroxysmal nocturnal hemoglobinuria (PNH) is caused by the clonal expansion of hematopoietic stem cells with mutations of the phosphatidylinositol glycan-class A gene (PIGA). PNH clones then fail to generate glycosylphosphatidylinositol (GPI) or to express a series of GPI-linked membrane proteins including complement-regulatory proteins, resulting in complement-mediated intravascular hemolysis and thrombosis. Bone marrow failure is another characteristic feature of PNH. It is currently considered that immune-mediated injury of hematopoietic cells is implicated in PNH marrow failure as well as in aplastic anemia, a well-known PNH-related disorder. There is increasing evidence that the autoimmune attack allows PNH clones to selectively survive in the injured marrow, leading to clinical manifestations characteristic of PNH. As candidate molecules that trigger the immune attack on marrow cells, stress-inducible membrane proteins and Wilms' tumor protein WT1 have been proposed. Among the stress-inducible proteins, GPI-linked proteins, such as cytomegalovirus glycoprotein UL16-binding protein, are distinct candidates that not only induce immune attack, but also allow PNH clones to survive the attack. Here, we overview the current understanding of the molecular pathogenesis of bone marrow failure in PNH.
Kawaguchi
Tatsuya
T
Department of Hematology and Infectious Diseases, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan. tatsu@kumamoto-u.ac.jp
Nakakuma
Hideki
H
D000741:Anemia, Aplastic / Q000150:complications* / Q000276:immunology; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001327:Autoimmune Diseases / Q000503:physiopathology; D001855:Bone Marrow Diseases / Q000503:physiopathology; D017261:Glycosylphosphatidylinositols / Q000172:deficiency; D006457:Hemoglobinuria, Paroxysmal / Q000150:complications / Q000235:genetics / Q000503:physiopathology*; D006801:Humans; D008565:Membrane Proteins / Q000235:genetics* / Q000378:metabolism; D011971:Receptors, Immunologic / Q000502:physiology; D055607:Receptors, Natural Killer Cell
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D017261:Glycosylphosphatidylinositols; D008565:Membrane Proteins; D011971:Receptors, Immunologic; D055607:Receptors, Natural Killer Cell; C080086:phosphatidylinositol glycan-class A protein; C481642:eculizumab